Clinical Trials
5 trialsNCT07557602 2026-04-29
mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults
Vaccine Company, Inc.
Phase 1 Not yet recruiting
NCT07478952 2026-03-24
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age
ModernaTX, Inc.
Phase 1 Recruiting
NCT06256484 2026-03-11
A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Atara Biotherapeutics
Phase 1 Terminated
NCT05831111 2025-09-30
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants
ModernaTX, Inc.
Phase 1 Active not recruiting
NCT06429800 2025-04-24
A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus
Atara Biotherapeutics
Phase 1 Withdrawn